share_log

12 Health Care Stocks Moving In Monday's Pre-Market Session

Benzinga Real-time News ·  Jan 30, 2023 21:07

Gainers

  • G Medical Innovations (NASDAQ:GMVD) stock moved upwards by 98.7% to $5.96 during Monday's pre-market session. The market value of their outstanding shares is at $8.4 million.
  • Aethlon Medical (NASDAQ:AEMD) stock rose 52.7% to $0.72. The market value of their outstanding shares is at $16.4 million.
  • Alterity Therapeutics (NASDAQ:ATHE) stock rose 14.83% to $4.49. The company's market cap stands at $180.1 million.
  • Evoke Pharma (NASDAQ:EVOK) shares rose 14.13% to $6.3. The company's market cap stands at $21.0 million.
  • Celyad Oncology (NASDAQ:CYAD) shares rose 13.95% to $1.47. The company's market cap stands at $33.2 million.
  • Scilex Holding (NASDAQ:SCLX) stock moved upwards by 13.5% to $10.0. The market value of their outstanding shares is at $1.4 billion.

Losers

  • Akanda (NASDAQ:AKAN) stock fell 14.2% to $0.29 during Monday's pre-market session. The market value of their outstanding shares is at $10.0 million.
  • Biotricity (NASDAQ:BTCY) stock decreased by 14.07% to $0.7. The company's market cap stands at $36.5 million.
  • Quince Therapeutics (NASDAQ:QNCX) shares fell 13.42% to $0.94. The company's market cap stands at $33.7 million.
  • Novo Integrated Sciences (NASDAQ:NVOS) stock decreased by 9.52% to $0.11. The company's market cap stands at $6.6 million.
  • Harpoon Therapeutics (NASDAQ:HARP) shares declined by 9.33% to $1.07. The market value of their outstanding shares is at $35.5 million.
  • ContraFect (NASDAQ:CFRX) shares decreased by 8.33% to $0.06. The company's market cap stands at $2.7 million. See Also:

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment